Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Amalia A. Winters"'
Autor:
Jorge Tuma, Antonio Carrasco, Jorge Castillo, Carlos Cruz, Alvaro Carrillo, Jose Ercilla, Carlos Yarleque, Jaime Cunza, Courtney E. Bartlett, Amalia A. Winters, Francisco J. Silva, Amit N. Patel M.D., M.S.
Publikováno v:
Cell Transplantation, Vol 25 (2016)
Cell therapy is an evolving option for patients with end-stage heart failure. First-generation cell therapy trials have had marginal success. Our goal was to evaluate retrograde delivery of allogeneic umbilical cord subepithelial cells (UCSECs) in pa
Externí odkaz:
https://doaj.org/article/03c2384215904ed7b1e18c624c76a2b5
Autor:
Amalia A. Winters, Sophia Bou-Ghannam, Hallie Thorp, Jose A. Hawayek, Donald L. Atkinson, Courtney E. Bartlett, Francisco J. Silva, Edward W. Hsu, Alonso P. Moreno, David A. Grainger, Amit N. Patel M.D., M.S.
Publikováno v:
Cell Transplantation, Vol 25 (2016)
The development of cell- and gene-based strategies for regenerative medicine offers a therapeutic option for the repair and potential regeneration of damaged cardiac tissue post-myocardial infarction (MI). Human umbilical cord subepithelial cell-deri
Externí odkaz:
https://doaj.org/article/29dbd15b6ede49a985e7039e45fda0ba
Publikováno v:
Heart Failure Clinics. 11:275-286
"During the past decade, studies in animals and humans have suggested that cell therapy has positive effects for the treatment of heart failure. This clinical effect may be mediated by angiogenesis and reduction in fibrosis rather than by regeneratio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c8b4036569719adc62b16b348f635585
https://doi.org/10.1016/j.hfc.2014.12.006
https://doi.org/10.1016/j.hfc.2014.12.006
Autor:
Amit N. Patel, Jorge Tuma, Carlos Cruz, Alvaro Carrillo, C. Yarleque, Antonio Carrasco, Amalia A. Winters, C. Bartlett, Jaime Cunza, Jorge J. Castillo, J. Ercilla, F. Silva
Publikováno v:
Cell Transplantation, Vol 25 (2016)
Cell therapy is an evolving option for patients with end-stage heart failure. First-generation cell therapy trials have had marginal success. Our goal was to evaluate retrograde delivery of allogeneic umbilical cord subepithelial cells (UCSECs) in pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e9c1e7709ede7326c8b30409bb588a9d
https://doaj.org/article/03c2384215904ed7b1e18c624c76a2b5
https://doaj.org/article/03c2384215904ed7b1e18c624c76a2b5
Autor:
Sanjay Mittal, Goekmen Turan, Amit N. Patel, Amalia A. Winters, Naresh Trehan, Timothy D. Henry, Hueseyin Ince
Publikováno v:
Stem cells translational medicine. 4(9)
Cell therapy is an evolving option for patients with end-stage heart failure and ongoing symptoms despite optimal medical therapy. Our goal was to evaluate retrograde bone marrow cell delivery in patients with either ischemic heart failure (IHF) or n
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::47f07fbe19fbc9aedb7d106ef3f177f6
https://pubmed.ncbi.nlm.nih.gov/26217065
https://pubmed.ncbi.nlm.nih.gov/26217065
Publikováno v:
The Journal of Heart and Lung Transplantation. 34:S181-S182
s S181 were frail. Frailty was independent of age, LVEF and renal function. Frailty (by FP or mFP) was associated with anemia, hypoalbuminemia and mortality (Figure). Using Cox proportional hazards model, frailty as assessed by mFP remained an indepe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::09d71567ef0cda9b6eba396f8a568bb9
https://doi.org/10.1016/j.healun.2015.01.495
https://doi.org/10.1016/j.healun.2015.01.495
Publikováno v:
The Journal of Heart and Lung Transplantation. 34:S245
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c22bcd77199965d2267e8b0d460ce4df
https://doi.org/10.1016/j.healun.2015.01.681
https://doi.org/10.1016/j.healun.2015.01.681
Publikováno v:
The Journal of Heart and Lung Transplantation. 34:S150
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1dcb826eccb4755603045d26687adf6f
https://doi.org/10.1016/j.healun.2015.01.404
https://doi.org/10.1016/j.healun.2015.01.404
Autor:
Medbery RL; Section of General Thoracic Surgery, Department of Surgery, Emory University School of Medicine, Atlanta, Georgia. Electronic address: rmedber@emory.edu., Winters A; Section of General Thoracic Surgery, Department of Surgery, Emory University School of Medicine, Atlanta, Georgia., Chen AY; Department of Otolaryngology, Emory University School of Medicine, Atlanta, Georgia., Rogers TE; Department of Pathology, Emory University School of Medicine, Atlanta, Georgia., Force SD; Section of General Thoracic Surgery, Department of Surgery, Emory University School of Medicine, Atlanta, Georgia.
Publikováno v:
The Annals of thoracic surgery [Ann Thorac Surg] 2019 Nov; Vol. 108 (5), pp. e301-e302. Date of Electronic Publication: 2019 Apr 09.
Autor:
Winters A; Division of Cardiothoracic Surgery, Emory University School of Medicine, Atlanta, Ga., Forcillo J; Division of Cardiothoracic Surgery, Emory University School of Medicine, Atlanta, Ga., Thourani VH; Division of Cardiothoracic Surgery, Emory University School of Medicine, Atlanta, Ga. Electronic address: vthoura@emory.edu.
Publikováno v:
The Journal of thoracic and cardiovascular surgery [J Thorac Cardiovasc Surg] 2016 May; Vol. 151 (5), pp. 1413-4. Date of Electronic Publication: 2016 Jan 07.